Osteosarcoma patients with high expression of Bcl-2 have lower long-term survival rates than those with low expression [343], and another study found that lung metastases had a higher frequency of positive Bcl-2 staining than primary tumour samples (84% versus 53%), though this difference was not significant most likely due to small sample size [308]. Here, BCL2 is linked to osteosarcoma.